IDEXX Laboratories, Inc. Financials

Market Capitalization $43.99 Billion as of July 1, 2025

Valuations Metrics as of Jul. 4, 2025

Trailing PE	50.51
Forward PE	45.74
Price to Sales TTM	$11.19
Price to Book MRQ	$30.50
Enterprise to Revenue	11.20
Enterprise to EBITDA	32.82

Financial Reports as of Mar. 31, 2025

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2025-03-31
Profit Margin	22.76%
Operating Margin	31.70%
Return on Assets TTM	22.98%
Return on Equity TTM	59.33%

Income Statement

Revenue TTM	$3,931,835,904
Revenue per Share TTM	$47.94
Quarterly Revenue Growth	3.60%
Gross Profit TTM	$2,409,235,968
EBITDA	$1,289,491,000
Net Income to Common TTM	$894,964,992
Diluted EPS TTM	$10.83
Quarterly Earnings Growth YoY	3.00%

Balance Sheet

Total Cash MRQ	$163,970,000
Total Cash per Share MRQ	$2.04
Total Debt MRQ	$
Total Debt to Equity MRQ	73.16
Current Ratio MRQ	1.16
Book Value per Share MRQ	$17.93

Cash Flow

Operating Cash Flow TTM	$968,377,984
Levered Free Cash Flow TTM	$761,150,144

IDXX Stock Info as of Jul. 4, 2025

Stock Statistics

Shares Outstanding	81,604,000
Float Shares	79,554,165
Avg 10 Volume	535,680
Avg 30 Volume	None
Shares Short	2,538,994
Short Ratio	4.98
Short % of Shares	4.13%
% Held by Insiders	0.67%
% Held by Institutions	97.51%

Stock Price Summary

Beta	1.55
Fifty Two Week Low	$356.14
Fifty Two Week High	$548.54
Fifty Two Week Change	11.15%
Day 50 MA	$505.41
Day 200 MA	$455.01

Dividends and Splits

Forward Annual Dividend Rate	$
Forward Annual Dividend Yield	%
Trailing Annual Dividend Rate	$0.00
Trailing Annual Dividend Yield	0.00%
Payout Ratio	0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date	2015-06-16